I am assuming the CORIS application to the FDA is now with the FDA.
CORIS is a De NOVA application. If approved CORIS will be a benchmark. No predicate exists.
So my attention shifts to the FDA STeP classification.The SaferTechnologies Program (STeP) stands apart from other FDA programs dueto its specific focus on medical devices that
significantly enhance safety forconditions with less serious morbidities and mortalities.Let’s delve into the differences:
- Breakthrough Devices Program (BDP) vs. STeP:
Eligibility:
- BDP targets devices that address life-threatening or debilitating conditions.
- STeP focuses on devices for conditions with less severe outcomes.
- Both programs aim to expedite access to innovative devices.
Benefits:
- BDP: Eligible for devices that provide substantial clinical benefit.
- STeP: Eligible for devices that enhance safety without meeting BDP criteria.
- BDP: Intensive FDA interaction, priority review, and expedited access.
- STeP: Collaborative interactions, timely feedback, and early engagement.
- Forums
- Charts
- NAN Chart
I am assuming the CORIS application to the FDA is now with the...
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.73 |
Change
0.210(5.97%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
$3.59 | $3.75 | $3.58 | $5.940M | 1.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 355 | $3.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.73 | 80333 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 3.850 |
1 | 6 | 3.750 |
1 | 1959 | 3.740 |
5 | 2231 | 3.730 |
2 | 3687 | 3.720 |
Price($) | Vol. | No. |
---|---|---|
3.630 | 53 | 3 |
3.740 | 223 | 1 |
3.750 | 761 | 2 |
3.760 | 215 | 1 |
3.770 | 215 | 1 |
Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |